Real-time enrollment status for this idiopathic inflammatory myopathies clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 2:26 PM UTC
| NCT Number | NCT06698796 |
| Recruiting Status | Recruiting |
| Condition | Idiopathic Inflammatory Myopathies |
| Phase | PHASE3 |
| Target Enrollment | 211 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | May 15, 2026 (May 15, 2026) |
As of July 17, 2026: Clinical trial NCT06698796 is currently recruiting participants. This phase3 study for idiopathic inflammatory myopathies is actively seeking new participants at 4 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06698796 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06698796 was last updated May 15, 2026 (May 15, 2026). HelloStudys verifies this status automatically.